1. Olsson, I., Asbrink, E., von Stedingk, M., von Stedingk, L. V. Changes in serum IgG antibody levels toBorrelia burgdorferi in patients treated for acrodermatitis chronica atrophicans. Acta Derm. Venerol. (Stockholm) 74 (1994) 424–428.
2. Hansen, K., Asbrink, E. Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans byB. burgdorferi flagellum enzyme-linked immunosorbent assay. J. Clin. Microbiol. 27 (1989) 545–551.
3. Asbrink, E., Hovmark, A. Successful cultivation of spirochetes from skin lesions of patients with erythema chronicum migrans and acrodermatitis chronica atrophicans. Acta Pathol. Microbiol. Immunol. Sect. B 93 (1985) 161–163.
4. Wienecke, R., Zöchling, N., Neubert, U., Schlüpen, E.-M., Meurer, M., Volkenandt, M. Molecular subtyping ofBorrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans. J. Invest. Dermatol. 103 (1994) 19–22.
5. Asbrink, E. Acrodermatitis chronica atrophicans. Clin. Dermatol. 11 (1993) 369–375.